Clinical Trial Update: Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF)

View source ↗

Summary

A completed clinical trial comparing dabigatran with vitamin K antagonists for stroke prevention in non-valvular atrial fibrillation, focusing on persistence/ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Dabigatran (Dabigatran etexilate)
• VKA (vitamin K antagonist)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Atrial Fibrillation | Status: COMPLETED | Results posted: 2019-04-19